Three Biotechs Bolstered by Positive News
Biotech has been a market laggard lately, but I’m eyeing three companies making recent progress.
Weekly Roundup: Waiting for the Market to Show Its Hand
During a volatile week, we updated the Portfolio’s shopping list, and locked in a sizable tech gain.
Iran Breakthrough?
The markets appeared to make a U-turn for the better on Thursday on potential progress with Tehran. Also, where’s the beef with the China summit?
10 Ways I Handle an Ugly Market (Including the Great Sacrifice)
Here’s my strategy for days like this, including how I make a shopping list, buy and take profits.
Several Signs Point to a Potential Blowout Earnings Season
As the doom and gloom crowd frets over Treasury yields, those yields in addition to other data, might be hinting at something positive.
Ondas Makes Three Key Acquisitions. Now I’m Planning to Buy More
Here’s why I’m planning to add to this autonomous systems and defense company, as well as buy two other names, in the $10K Portfolio.
About That Apple-Qualcomm News: 8 Key Items Shaping the Stock Market Thursday
Following up on Meta’s Connect event, U.S. and China kick the can and other headlines moving the market this morning.
Pressures Mounting as Market Moves Toward Potential Seasonal Low
We’re staying on the sidelines until we have more clarity on several macro developments.
What If OpenAI Fails In 2027?
A lot is riding on OpenAI being able to raise a huge sum of capital in coming years — just ask Oracle. But what if it flops?